Lipotes vexillifer (Yangtze River dolphin): 103086653
Help
Entry
103086653 CDS
T03090
Symbol
PRKCG
Name
(RefSeq) protein kinase C gamma type
KO
K19663
classical protein kinase C gamma type [EC:
2.7.11.13
]
Organism
lve
Lipotes vexillifer (Yangtze River dolphin)
Pathway
lve01521
EGFR tyrosine kinase inhibitor resistance
lve04010
MAPK signaling pathway
lve04012
ErbB signaling pathway
lve04014
Ras signaling pathway
lve04015
Rap1 signaling pathway
lve04020
Calcium signaling pathway
lve04066
HIF-1 signaling pathway
lve04070
Phosphatidylinositol signaling system
lve04071
Sphingolipid signaling pathway
lve04082
Neuroactive ligand signaling
lve04150
mTOR signaling pathway
lve04270
Vascular smooth muscle contraction
lve04310
Wnt signaling pathway
lve04370
VEGF signaling pathway
lve04510
Focal adhesion
lve04540
Gap junction
lve04613
Neutrophil extracellular trap formation
lve04650
Natural killer cell mediated cytotoxicity
lve04666
Fc gamma R-mediated phagocytosis
lve04670
Leukocyte transendothelial migration
lve04713
Circadian entrainment
lve04720
Long-term potentiation
lve04723
Retrograde endocannabinoid signaling
lve04724
Glutamatergic synapse
lve04725
Cholinergic synapse
lve04726
Serotonergic synapse
lve04727
GABAergic synapse
lve04728
Dopaminergic synapse
lve04730
Long-term depression
lve04750
Inflammatory mediator regulation of TRP channels
lve04911
Insulin secretion
lve04916
Melanogenesis
lve04918
Thyroid hormone synthesis
lve04919
Thyroid hormone signaling pathway
lve04921
Oxytocin signaling pathway
lve04925
Aldosterone synthesis and secretion
lve04928
Parathyroid hormone synthesis, secretion and action
lve04929
GnRH secretion
lve04935
Growth hormone synthesis, secretion and action
lve04960
Aldosterone-regulated sodium reabsorption
lve04961
Endocrine and other factor-regulated calcium reabsorption
lve04970
Salivary secretion
lve04971
Gastric acid secretion
lve04972
Pancreatic secretion
lve05017
Spinocerebellar ataxia
lve05022
Pathways of neurodegeneration - multiple diseases
lve05031
Amphetamine addiction
lve05032
Morphine addiction
lve05143
African trypanosomiasis
lve05146
Amoebiasis
lve05161
Hepatitis B
lve05163
Human cytomegalovirus infection
lve05170
Human immunodeficiency virus 1 infection
lve05171
Coronavirus disease - COVID-19
lve05200
Pathways in cancer
lve05205
Proteoglycans in cancer
lve05206
MicroRNAs in cancer
lve05207
Chemical carcinogenesis - receptor activation
lve05214
Glioma
lve05223
Non-small cell lung cancer
lve05225
Hepatocellular carcinoma
lve05231
Choline metabolism in cancer
lve05415
Diabetic cardiomyopathy
Brite
KEGG Orthology (KO) [BR:
lve00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
103086653 (PRKCG)
04012 ErbB signaling pathway
103086653 (PRKCG)
04014 Ras signaling pathway
103086653 (PRKCG)
04015 Rap1 signaling pathway
103086653 (PRKCG)
04310 Wnt signaling pathway
103086653 (PRKCG)
04370 VEGF signaling pathway
103086653 (PRKCG)
04066 HIF-1 signaling pathway
103086653 (PRKCG)
04020 Calcium signaling pathway
103086653 (PRKCG)
04070 Phosphatidylinositol signaling system
103086653 (PRKCG)
04071 Sphingolipid signaling pathway
103086653 (PRKCG)
04150 mTOR signaling pathway
103086653 (PRKCG)
09133 Signaling molecules and interaction
04082 Neuroactive ligand signaling
103086653 (PRKCG)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04510 Focal adhesion
103086653 (PRKCG)
04540 Gap junction
103086653 (PRKCG)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
103086653 (PRKCG)
04650 Natural killer cell mediated cytotoxicity
103086653 (PRKCG)
04666 Fc gamma R-mediated phagocytosis
103086653 (PRKCG)
04670 Leukocyte transendothelial migration
103086653 (PRKCG)
09152 Endocrine system
04911 Insulin secretion
103086653 (PRKCG)
04929 GnRH secretion
103086653 (PRKCG)
04921 Oxytocin signaling pathway
103086653 (PRKCG)
04935 Growth hormone synthesis, secretion and action
103086653 (PRKCG)
04918 Thyroid hormone synthesis
103086653 (PRKCG)
04919 Thyroid hormone signaling pathway
103086653 (PRKCG)
04928 Parathyroid hormone synthesis, secretion and action
103086653 (PRKCG)
04916 Melanogenesis
103086653 (PRKCG)
04925 Aldosterone synthesis and secretion
103086653 (PRKCG)
09153 Circulatory system
04270 Vascular smooth muscle contraction
103086653 (PRKCG)
09154 Digestive system
04970 Salivary secretion
103086653 (PRKCG)
04971 Gastric acid secretion
103086653 (PRKCG)
04972 Pancreatic secretion
103086653 (PRKCG)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
103086653 (PRKCG)
04961 Endocrine and other factor-regulated calcium reabsorption
103086653 (PRKCG)
09156 Nervous system
04724 Glutamatergic synapse
103086653 (PRKCG)
04727 GABAergic synapse
103086653 (PRKCG)
04725 Cholinergic synapse
103086653 (PRKCG)
04728 Dopaminergic synapse
103086653 (PRKCG)
04726 Serotonergic synapse
103086653 (PRKCG)
04720 Long-term potentiation
103086653 (PRKCG)
04730 Long-term depression
103086653 (PRKCG)
04723 Retrograde endocannabinoid signaling
103086653 (PRKCG)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
103086653 (PRKCG)
09159 Environmental adaptation
04713 Circadian entrainment
103086653 (PRKCG)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
103086653 (PRKCG)
05206 MicroRNAs in cancer
103086653 (PRKCG)
05205 Proteoglycans in cancer
103086653 (PRKCG)
05207 Chemical carcinogenesis - receptor activation
103086653 (PRKCG)
05231 Choline metabolism in cancer
103086653 (PRKCG)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
103086653 (PRKCG)
05214 Glioma
103086653 (PRKCG)
05223 Non-small cell lung cancer
103086653 (PRKCG)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
103086653 (PRKCG)
05161 Hepatitis B
103086653 (PRKCG)
05171 Coronavirus disease - COVID-19
103086653 (PRKCG)
05163 Human cytomegalovirus infection
103086653 (PRKCG)
09174 Infectious disease: parasitic
05146 Amoebiasis
103086653 (PRKCG)
05143 African trypanosomiasis
103086653 (PRKCG)
09164 Neurodegenerative disease
05017 Spinocerebellar ataxia
103086653 (PRKCG)
05022 Pathways of neurodegeneration - multiple diseases
103086653 (PRKCG)
09165 Substance dependence
05031 Amphetamine addiction
103086653 (PRKCG)
05032 Morphine addiction
103086653 (PRKCG)
09166 Cardiovascular disease
05415 Diabetic cardiomyopathy
103086653 (PRKCG)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
103086653 (PRKCG)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
lve01001
]
103086653 (PRKCG)
Enzymes [BR:
lve01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.13 protein kinase C
103086653 (PRKCG)
Protein kinases [BR:
lve01001
]
Serine/threonine kinases: AGC group
PKC family [OT]
103086653 (PRKCG)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Pkinase
C1_1
PK_Tyr_Ser-Thr
C2
Pkinase_C
ABC1
Kinase-like
Motif
Other DBs
NCBI-GeneID:
103086653
NCBI-ProteinID:
XP_007459094
UniProt:
A0A340XII0
LinkDB
All DBs
Position
Unknown
AA seq
697 aa
AA seq
DB search
MAGLGPGGGDSEGGPRPLFCRKGALRQKVVHEVKSHKFTARFFKQPTFCSHCTDFIWGIG
KQGLQCQVCSFVVHRRCHEFVTFECPGAGKGPQTDDPRNKHKFRLHSYSSPTFCDHCGSL
LYGLVHQGMKCSCCEMNVHRRCVRSVPSLCGVDHTERRGRLQLEIRAPTSDEIHITVGEA
RNLIPMDPNGLSDPYVKLKLIPDPRNLTKQKTRTVKATLNPVWNETFVFNLKPGDVERRL
SVEVWDWDRTSRNDFMGAMSFGVSELLKVPVDGWYKLLNQEEGEYYNVPVADADNCSLLQ
KFEACNYPLELYERVRMGPSSSPTPSPSPSPTDPKRCFFGASPGRLHISDFSFLMVLGKG
SFGKVMLAERRGSDELYAIKILKKDVIVQDDDVDCTLVEKRVLALGGRGPGGRPHFLTQL
HSTFQTPDRLYFVMEYVTGGDLMYHIQQLGKFKEPHAAFYAAEIAIGLFFLHNQGIIYRD
LKLDNVMLDAEGHIKITDFGMCKENVFPGTTTRTFCGTPDYIAPEIIAYQPYGKSVDWWS
FGVLLYEMLAGQPPFDGEDEEELFQAIMEQTVTYPKSLSREAVAICKGFLTKHPAKRLGS
GPDGEPTIRAHGFFRWIDWERLERLEIAPPFRPRPCGRSGENFDKFFTRAAPALTPPDRL
VLASIDQTEFQGFTYVNPDFVHPDARSPISPAPVPVM
NT seq
2094 nt
NT seq
+upstream
nt +downstream
nt
atggcaggcctgggccccggcggaggcgattcagaggggggaccccggcccctgttttgc
agaaagggggctctgaggcagaaggtggtccacgaagtcaagagccacaagttcaccgct
cgcttcttcaagcagccaaccttctgcagccactgcactgacttcatatgggggattgga
aaacaaggcctgcaatgtcaagtctgcagctttgtggttcatcgacgatgccacgaattt
gtgaccttcgagtgtccaggcgctgggaagggcccccagacggacgatccccggaacaag
cacaagttccgtctgcacagctacagcagccccaccttctgcgaccactgtggctccctc
ctttacgggctggtgcaccagggcatgaagtgctcctgctgcgagatgaacgtgcaccgg
cgctgtgtgcgcagcgtgccctctctgtgcggtgtggaccacacggagcgccgcggccgc
ctgcagctggaaatccgggctcccacttcggatgagatccacatcacggttggcgaggcc
cgtaacctcatcccaatggaccccaatggtctgtctgatccctatgtgaaactgaagctc
atcccagatcctcggaatttgacaaaacagaagacccggacggtgaaagccacgctaaac
cctgtgtggaacgagacctttgtgttcaacctgaagccaggggacgtggagcgccggctc
agcgtggaggtgtgggactgggaccggacttcccgcaacgacttcatgggtgccatgtcc
tttggcgtctcggagctgctcaaggttcccgtggacggctggtacaagttactgaaccag
gaggagggcgaatattacaatgtgccagtggctgatgctgacaactgcagcctcctccag
aagtttgaggcctgtaactaccccctggaactgtacgagagggtgcggatgggcccttct
tcctctcccaccccctccccgtctccgagtcccaccgaccccaagcgctgtttcttcggg
gcaagccctggacgtctgcacatctctgacttcagcttcctcatggttctaggaaaaggc
agttttgggaaggtgatgctggccgagcgcaggggctccgatgagctctatgccatcaag
atcctgaagaaagacgtgattgtccaggatgacgatgtggactgcaccctggtggagaaa
cgcgtattagccctggggggtcgaggccccggaggccggccccactttctcacccagctt
cactccactttccagaccccggatcgcctgtatttcgtgatggagtatgtcactgggggc
gacttgatgtaccacattcagcagctgggcaagtttaaggagccccatgcagcgttctac
gcagcagaaatcgccatcggcctcttcttccttcacaaccagggcatcatctatcgggac
ctgaaactggacaacgtgatgctggatgctgaaggacacatcaaaatcactgactttggc
atgtgtaaggagaacgtcttccccgggaccacaactcgcaccttctgtgggaccccagac
tacatagcccccgagatcattgcctaccagccctatgggaagtctgtcgactggtggtcc
tttggggtcctgctgtatgagatgttggcggggcagcccccctttgatggggaagacgag
gaggaactgttccaggccatcatggaacaaactgtcacctaccccaagtcactttcccgg
gaagctgtggccatctgcaaggggttcctaaccaagcacccagcaaagcgcctgggctcg
gggccagatggagaacccaccatccgagctcatggctttttccgctggatcgactgggaa
cggctggaacgattagagatcgcgcctcctttcagaccccgcccgtgtggccgcagcggc
gagaacttcgacaagttcttcacgcgggcggcgccagcgttgactcccccagaccgccta
gttctggccagcatcgaccaaactgaattccaaggcttcacctatgtcaacccggatttc
gtgcacccggatgcccgcagccccatcagcccagcacccgtgccagtcatgtaa
DBGET
integrated database retrieval system
